Literature DB >> 15968395

Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.

Markus Blome1, Frank Isgro, Arndt Holger Kiessling, Jan Skuras, Hannelore Haubelt, Peter Hellstern, Werner Saggau.   

Abstract

We investigated the relationship between factor XIII, fibrinogen, blood coagulation screening tests and postoperative bleeding in 98 patients undergoing cardiopulmonary bypass (CPB) surgery. All patients received aprotinin. Blood samples were collected preoperatively (T1),after termination of CPB (T2),12 h (T3) and 24 h (T4) after surgery to determine FXIII activity, fibrinogen, platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT) and D-dimers (DD). Laboratory results were correlated with the chest tube drainage 24 h after surgery and compared between patients with 24-hour chest tube drain volumes in the lower (Group 1) with those in the upper tertile (Group 3). Median FXIII and fibrinogen levels dropped by 33.9% and 34.2%, respectively, during CPB. No association between FXIII activity and the extent of postoperative bleeding was found. However, chest tube bleeding was significantly correlated with preoperative and postoperative fibrinogen. This was confirmed by comparing Groups 1 and 3. Group 3 patients had significantly lower fibrinogen levels than Group 1 at T1 - T4, although most fibrinogen values were within or above the reference range (medians, g/l: 3.5 vs. 4.0, p = 0.043 at T1; 2.3 vs. 2.7, p = 0.015 at T2; 2.9 vs. 3.3, p = 0.008 at T3; 4.2 vs. 5.2, p = 0.002 at T4). There was also a significant relationship of platelet count, PT and APTT, as measured after CPB (T2), with postoperative chest tube drainage. In conclusion, plasma FXIII activity does not influence postoperative bleeding in patients undergoing CPB surgery. There is however an inverse association between preoperative or postoperative plasma fibrinogen levels and postoperative bleeding. These findings indicate a modulation of postoperative bleeding by fibrinogen levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968395     DOI: 10.1160/TH04-12-0799

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  30 in total

1.  Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L.

Authors:  Cristina Solomon; Niels Rahe-Meyer
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

2.  High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.

Authors:  Satoru Ogawa; James E Richardson; Tetsuro Sakai; Masahiro Ide; Kenichi A Tanaka
Journal:  J Anesth       Date:  2011-10-19       Impact factor: 2.078

3.  [Bedside thrombelastography].

Authors:  C von Heymann; C Rosenthal; T Volk; C Spies
Journal:  Anaesthesist       Date:  2007-12       Impact factor: 1.041

4.  Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart.

Authors:  Lejla Selimović Čeke; Semir Imamović; Farid Ljuca; Zoran Jerkić; Goran Imamović; Munevera Hadžimešić; Aida Pojskić; Jasmina Kovčić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

5.  7 Procoagulators.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

6.  Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.

Authors:  C Solomon; U Pichlmaier; H Schoechl; C Hagl; K Raymondos; D Scheinichen; W Koppert; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2010-03-26       Impact factor: 9.166

7.  Predictors of hypofibrinogenemia in blunt trauma patients on admission.

Authors:  Yoshinobu Kimura; Saori Kimura; Shinzou Sumita; Michiaki Yamakage
Journal:  J Anesth       Date:  2014-08-12       Impact factor: 2.078

8.  Dynamics of factor XIII levels after open heart surgery for congenital heart defects: do cyanotic and acyanotic patients differ?

Authors:  Leo A Bockeria; Natalia N Samsonova; Ivan A Yurlov; Ludmila G Klimovich; Elena F Kozar; Eva H N Olsen; Sergey B Zaets
Journal:  Pediatr Cardiol       Date:  2014-04-09       Impact factor: 1.655

Review 9.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

Review 10.  Fibrinogen concentrate in bleeding patients.

Authors:  Anne Wikkelsø; Jens Lunde; Mathias Johansen; Jakob Stensballe; Jørn Wetterslev; Ann Merete Møller; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.